Senti Biosciences Holdings (SNTI) EBT Margin (2021 - 2023)
Senti Biosciences Holdings (SNTI) posted quarterly EBT Margin of 29070.71% for Q3 2023, down 2416154.0% year-over-year from N/an in Q3 2022, and down 179.93% quarter-over-quarter from 10385.01% in Q2 2023.
Senti Biosciences Holdings (SNTI) EBT Margin (2021 - 2023) Analysis & Trends
Senti Biosciences Holdings' EBT Margin history runs 3 years deep, the most recent figure standing at 29070.71% for Q3 2023.
- In Q3 2023, EBT Margin fell 2416154.0% year-over-year to 29070.71%; the TTM figure through Jun 2024 stood at 91032.84% (down 8321207.0% YoY), while the FY2025 annual figure was 761363.64%, changed N/A from the prior year.
- EBT Margin for Q3 2023 stood at 29070.71%, down from 10385.01% in the prior quarter.
- The five-year high for EBT Margin was 1035.27% in Q3 2021, with the low at 99737.29% in Q4 2022.
- The 3-year median for EBT Margin is 5857.57% (2023), against an average of 16946.4%.
- Peak annual rise in EBT Margin reached 387389 bps in 2022, while the deepest fall reached 8934500 bps in 2022.
- Senti Biosciences Holdings' EBT Margin stood at 10392.29% in 2021, then tumbled by 860 bps to 99737.29% in 2022, then surged by 71 bps to 29070.71% in 2023.
- Business Quant data shows SNTI's EBT Margin at 29070.71% in Q3 2023, 10385.01% in Q2 2023, and 5666.25% in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn | 13.77% |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | -25.06% |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | -2.67% |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | 12.09% |
| 10 | Senti Biosciences Holdings | 12.61 Mn | 12.61 Mn | - | -84,905.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -29,070.71% |
| Jun 30, 2023 | -10,385.01% |
| Mar 31, 2023 | -5,666.25% |
| Dec 31, 2022 | -99,737.29% |
| Sep 30, 2022 | -4,909.17% |
| Jun 30, 2022 | -6,048.90% |
| Mar 31, 2022 | -1,062.94% |
| Dec 31, 2021 | -10,392.29% |
| Sep 30, 2021 | -1,035.27% |
| Jun 30, 2021 | -1,156.17% |